In summary, This study identified piR-017724 as a new HCC biomarker that participates in the occurrence and development of HCC by targeting PLIN3 as a new mechanism, which provides new insights into the clinical application of piR-017724 in the treatment of HCC. This evidence concerns the gene PIR and hepatocellular carcinoma.